- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06024863
Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram (SEEPRED)
September 6, 2023 updated by: Centre Hospitalier Universitaire de Saint Etienne
Optimising Screening of Intermediate to High-risk Asymptomatic Sportsmen With Exercise Electrocardiogram. The SEEPRED Study.
The importance of exercise electrocardiogram (ECG) is still controversial in the prevention of cardiac events among sportsmen.
The aim of this study was to assess the relevance of exercise electrocardiogram (ECG) as a significant prognostic marker for cardiovascular events when any cardiovascular disease (CVD) risk factors are present.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
The SEEPRED (Sport, Exercise ECG, prediction) prospective cohort study included leisure time sportsmen over 35 years old who performed exercise electrocardiogram (ECG) screening in the Sports Medicine Unit of the University Hospital of Saint-Etienne from September 2011 to April 2016.
Personal, familial history and physical examination were systematically performed before maximal exercise electrocardiogram (ECG).
Cardiovascular events and changes in physical activity were searched after exercise electrocardiogram (ECG).
Study Type
Observational
Enrollment (Actual)
1500
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Saint-Étienne, France, 42055
- CENTRE HOSPITALIER DE SAINT-ETIENNE
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Sampling Method
Non-Probability Sample
Study Population
Leisure tim sportmen over 35 years.
Description
Inclusion criteria:
- Patients referred as asymptomatic by their general practitioner for an exercise electrocardiogram (ECG) screening test carried out as a standard procedure for resuming physical activity
- Patients referred as a systematic pre-participation screening to be declared an athlete.
Exclusion criteria:
- Patients with coronary artery disease (CAD) and
- Patients with uninterpretable ST segment due to bundle branch block
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Sportsmen
Sportsmen (at least 1 hour of physical activity per week) over 35 years of age, referred by their doctor for a screening stress test on a bicycle ergometer in the sports medicine unit from September 2011 to August 2014
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Silent Myocardial ischemia (SMI)
Time Frame: Day 1
|
Determine the frequency of exercise-induced silent myocardial ischemia (SMI).
|
Day 1
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Gender record
Time Frame: Day 1
|
Gender will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Age record
Time Frame: Day 1
|
Age will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Physical activity levels record
Time Frame: Day 1
|
Physical activity levels will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Treatment record
Time Frame: Day 1
|
Treatment will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Cardiovascular disease (CVD) risk factors record
Time Frame: Day 1
|
Cardiovascular disease (CVD) risk factors will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Body mass index record
Time Frame: Day 1
|
Body mass index will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Score>5% record
Time Frame: Day 1
|
SCORE >5% will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Maximal heart record
Time Frame: Day 1
|
Maximal heart rate will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Maximal aerobic power record
Time Frame: Day 1
|
Maximal aerobic power will be recording during medical consultation in order to predict positive exercise ECG
|
Day 1
|
|
Maximal blood lactate level record
Time Frame: Day 1
|
Maximal blood lactate level will be collected in order to predict positive exercise ECG
|
Day 1
|
|
Suspected SMI
Time Frame: Day 1
|
Exercise ECG screening test
|
Day 1
|
|
Confirmed SMI
Time Frame: Day 1
|
Exercise ECG screening test
|
Day 1
|
|
Cardiovascular events
Time Frame: Day 1
|
Exercise ECG screening test
|
Day 1
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: DAVID HUPIN, MD, CHU ST Etienne
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 1, 2011
Primary Completion (Actual)
January 1, 2014
Study Completion (Actual)
January 1, 2019
Study Registration Dates
First Submitted
July 27, 2023
First Submitted That Met QC Criteria
August 29, 2023
First Posted (Actual)
September 6, 2023
Study Record Updates
Last Update Posted (Actual)
September 8, 2023
Last Update Submitted That Met QC Criteria
September 6, 2023
Last Verified
March 1, 2022
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- IRBN372016/CHUSTE
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Electrocardiography
-
University of Toledo Health Science CampusCompletedElectrocardiographyUnited States
-
Perin Health DevicesCompletedElectrocardiography | Monitoring, Physiologic | ECGUnited States
-
Norwegian University of Science and TechnologySykehuset Innlandet HFCompletedElectrocardiography | Catheterization, PeripheralNorway
-
BayerCompletedElectrocardiography | QTc EvaluationSingapore, Australia, Germany, United Kingdom
-
Guangdong Provincial People's HospitalActive, not recruitingElectrocardiography | Acute Myocardial Infarction (AMI) | Artifical IntelligenceChina
-
National University of Natural MedicineUniversity of Manitoba; Oregon Health and Science UniversityCompletedElectrocardiography | Electroencephalography | Respiratory Rate | Surveys and QuestionnairesUnited States
-
Seoul National University HospitalUnknownBlood Pressure | Electrocardiography | Pediatrics | AccelerometerKorea, Republic of
-
Maxima Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentRecruitingCaesarean Section | Electrocardiography | Cardiotocography | Fetal Monitoring | Non-invasiveNetherlands
-
Konya City HospitalCompletedIn Vitro Fertilization | Cardiac Electrophysiology | Reproductive Endocrinology | Estradiol | Electrocardiography (ECG)Turkey
-
Assiut UniversityNot yet recruitingHypertension | Circadian Rhythm | Electrocardiography | Ventricular Function | Blood Pressure Monitoring, Ambulatory
Clinical Trials on Screening stress test on a bicycle ergometer (usual practise)
-
Vastra Gotaland RegionGöteborg UniversityCompletedHypermobile Ehlers-Danlos Syndrome | Joint Hypermobility SyndromeSweden
-
Joslin Diabetes CenterCompletedHypoglycemia | Physical Activity | Roux-en-Y Gastric Bypass | Post-bariatric HypoglycemiaUnited States
-
Georgetown UniversityCompletedChronic Fatigue Syndrome
-
Poznan University of Physical EducationDavid C. Nieman; Tomasz Cisoń; Joanna Szurkowska; Mirosława Gałęcka; Dariusz Sitkowski and other collaboratorsCompleted
-
Selda SarıkayaZonguldak Bulent Ecevit UniversityCompletedCOVID-19 | COVID-19 PneumoniaTurkey
-
Rennes University HospitalCompletedLeft Ventricular Assist Devices PatientsFrance
-
Centre Hospitalier Intercommunal CreteilUniversity Hospital, Paris; Hôpital Necker-Enfants Malades; Groupe Hospitalier... and other collaboratorsCompletedStreptococcal PharyngitisFrance
-
University Hospital, GrenobleMinistry of Health, France; Organon; Societe Francophone de Nutrition Enterale... and other collaboratorsCompletedChronic Respiratory Failure | Nutritional DepletionFrance, Switzerland
-
Julio RamirezUniversity of LouisvilleTerminatedOsteomyelitisUnited States